Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study
Abstract Background Endometrial cancer is the most common gynecological malignancy; however, there is no Door Knobs useful blood diagnostic biomarker.This study aimed to determine the utility of tissue factor pathway inhibitor 2 (TFPI2), a biomarker of ovarian cancer, as a diagnostic marker for endometrial cancer.Methods We examined serum TFPI2 lev